Rowe lab wrote an article titled 'Level-up: Looking to Epigenetics for the Next Immunotherapy Breakthrough' for Cancer Research UK
Published:
/filters:format(webp)/prod01/channel_396/centre-for-epigenetics/media/epigenetics/news-images/0driplmh.png)
Fig. 1
Checkpoint inhibitors have utterly changed the immunotherapy landscape – but there could be a different kind of checkpoint just waiting to be targeted. Here, Helen Rowe tells us why epigenetic checkpoint blockade looks so promising… To read the full article, please follow this link: Level-up: Looking to epigenetics for the next immunotherapy breakthrough - Cancer Research UK - Cancer News